These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4566777)

  • 21. Prolongation of skin allografts after oral application of ALS in rats.
    Seifert J; Ring J; Brendel W
    Nature; 1974 Jun; 249(459):776. PubMed ID: 4599458
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoradiographic evidence for the origin of cells constituting arterial intimal thickening in experimental cardiac allografts.
    Laden AM
    J Reticuloendothel Soc; 1972 May; 11(5):524-33. PubMed ID: 4556444
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of didemnin B in suppressing allograft rejection in mice and rats.
    Yuh DD; Zurcher RP; Carmichael PG; Morris RE
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1141-3. PubMed ID: 2650081
    [No Abstract]   [Full Text] [Related]  

  • 24. Survival of tumor allografts in rats treated with antithymocyte serum.
    Abandowitz HM; Basrur PK
    Z Naturforsch C; 1973; 28(9):631-2. PubMed ID: 4272308
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of antiplatelet drugs on graft atherosclerosis in rat heterotopic cardiac allografts.
    Muskett A; Burton NA; Eichwald EJ; Shelby J; Hendrickson M; Sullivan JJ
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):74-6. PubMed ID: 3303572
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of arterial lesions in cardiac allografts.
    Gordon JL
    Transplantation; 1972 Oct; 14(4):511. PubMed ID: 4566167
    [No Abstract]   [Full Text] [Related]  

  • 28. Antigenic and immunogenic capacities of cell membranes with and without antilymphocyte serum.
    Matolo NM; Reemtsma K; DeWitt CW
    Surg Forum; 1971; 22():282-4. PubMed ID: 4941315
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
    Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of pyridinolcarbamate on induced atherosclerosis in cynomolgus monkeys (Macaca ira).
    Malinow MR; McLaughlin P; Perley A
    Atherosclerosis; 1972; 15(1):31-6. PubMed ID: 4111120
    [No Abstract]   [Full Text] [Related]  

  • 31. Bromocriptine plus suboptimal cyclosporine treatment abrogates acute rejection of rat cardiac allografts.
    Di Stefano R; Carmellini M; Carobbi A; Vaglini F; Petrini M; Ricci F; Mosca F; Malvaldi G
    Transplant Proc; 1990 Aug; 22(4):2015-6. PubMed ID: 2389514
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibition of rat heart and kidney allograft rejection by photochemical treatment of the recipient].
    Oesterwitz H; Gruner S; Schneider W
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):199-201. PubMed ID: 2095643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xanthines: ideal immunosuppressants for combination with cyclosporine?
    Lin Y; Segers C; Mikhalsky D; Schönharting M; Waer M
    Transplant Proc; 1996 Dec; 28(6):3102. PubMed ID: 8962202
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of oxisuran as an immunosuppressive agent.
    Husberg B; Penn I; Freedman HH
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):669-74. PubMed ID: 4592172
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of the immunosuppressive activity of FK 506 in rat islet allografts.
    Yasunami Y; Ryu S; Kamei T
    Transplant Proc; 1990 Apr; 22(2):875. PubMed ID: 1691557
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathology of canine renal allografts prolonged by sheep antilymphocyte plasma.
    Fox M; Diethelm AG; Glassock RJ; Orr WM; Dubernard JM; Stuart FP; Dammin GJ; Murray JE
    Invest Urol; 1971 Mar; 8(5):563-74. PubMed ID: 4104119
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Escherichia coli endotoxin on skin allografts in mice.
    Skopińska E; Oluwasanmi JO
    Folia Biol (Praha); 1972; 18(4):270-6. PubMed ID: 4559930
    [No Abstract]   [Full Text] [Related]  

  • 39. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.